Price-file publication check · 45 CFR § 180
B · 85
This hospital's published file contains most of what § 180 requires.
●Machine-readable file published: assessment threshold met
●Gross / standard charges: assessment threshold met
●Discounted cash price: assessment threshold met
●Payer-specific negotiated rates: assessment threshold met
○Min / max negotiated charges: below assessment threshold
●Free, public, no login required: assessment threshold met
Procedures listed
5,066
Insurances with rates
19
CPT / HCPCS codes
2,487
Most expensive procedures (gross)
A9513
$77,415
LUTETIUM LU 177 DOTATATE 10 MCI/ML (370 MBQ/ML) INTRAVENOUS SOLUTION
Gross
$286,723
A9607
$63,041
LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN 27 MCI/ML (1,000 MBQ/ML) IV SOLN
Gross
$233,486
J9043
$58,116
CABAZITAXEL 10 MG/ML (FIRST DILUTION) INTRAVENOUS SOLUTION
Gross
$215,244
J9347
$52,410
TREMELIMUMAB-ACTL 20 MG/ML INTRAVENOUS SOLUTION
Gross
$194,111
J9226
$50,131
HISTRELIN 50 MG (65 MCG/DAY) IMPLANT KIT
Gross
$185,672
J3357
$36,068
USTEKINUMAB 90 MG/ML SUBCUTANEOUS SYRINGE
Gross
$133,587
J9359
$35,941
LONCASTUXIMAB TESIRINE-LPYL 10 MG INTRAVENOUS SOLUTION
Gross
$133,113
J9229
$30,286
INOTUZUMAB OZOGAMICIN 0.9 MG(0.25 MG/ML INITIAL CONCENTRATION) IV SOLN
Gross
$112,169
149
$27,473
DYSEQUILIBRIUM
Gross
$101,751
563
$27,410
FRACTURE, SPRAIN, STRAIN AND DISLOCATION EXCEPT FEMUR, HIP, PELVIS AND THIGH WITHOUT MCC
Gross
$101,518
J2350
$26,104
OCRELIZUMAB 30 MG/ML INTRAVENOUS SOLUTION
Gross
$96,683
J2507
$24,187
PEGLOTICASE 8 MG/ML INTRAVENOUS SOLUTION
Gross
$89,582
A9606
$23,986
RA-223 XOFIGO
Gross
$88,837
548
$23,837
SEPTIC ARTHRITIS WITH MCC
Gross
$88,284
J9309
$23,538
POLATUZUMAB VEDOTIN-PIIQ 140 MG INTRAVENOUS SOLUTION
Gross
$87,177
J9298
$19,530
NIVOLUMAB 240 MG-RELATLIMAB-RMBW 80 MG/20 ML INTRAVENOUS SOLUTION
Gross
$72,332
974
$19,334
HIV WITH MAJOR RELATED CONDITION WITH MCC
Gross
$71,608
386
$19,321
INFLAMMATORY BOWEL DISEASE WITH CC
Gross
$71,560
J9345
$18,645
RETIFANLIMAB-DLWR 500 MG/20 ML INTRAVENOUS SOLUTION
Gross
$69,057
662
$18,496
MINOR BLADDER PROCEDURES WITH MCC
Gross
$68,502
J1628
$18,413
GUSELKUMAB 200 MG/20 ML (10 MG/ML) INTRAVENOUS SOLUTION
Gross
$68,196
813
$16,283
COAGULATION DISORDERS
Gross
$60,306
152
$16,216
OTITIS MEDIA AND URI WITH MCC
Gross
$60,060
J9042
$16,052
BRENTUXIMAB VEDOTIN 50 MG INTRAVENOUS SOLUTION
Gross
$59,452
542
$15,016
PATHOLOGICAL FRACTURES AND MUSCULOSKELETAL AND CONNECTIVE TISSUE MALIGNANCY WITH MCC
Gross
$55,616
J9022
$14,676
ATEZOLIZUMAB 1,200 MG/20 ML (60 MG/ML) INTRAVENOUS SOLUTION
Gross
$54,356
382
$14,325
COMPLICATED PEPTIC ULCER WITHOUT CC/MCC
Gross
$53,055
064
$14,305
INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH MCC
Gross
$52,982
J9119
$13,817
CEMIPLIMAB-RWLC 50 MG/ML INTRAVENOUS SOLUTION
Gross
$51,173
497
$13,416
LOCAL EXCISION AND REMOVAL OF INTERNAL FIXATION DEVICES EXCEPT HIP AND FEMUR WITHOUT CC/MCC
Gross
$49,690
J9144
$13,303
DARATUMUMAB 1,800 MG-HYALURONIDASE-FIHJ 30,000 UNIT/15 ML SUBCUT SOLN
Gross
$49,272
J9380
$13,224
TECLISTAMAB-CQYV 90 MG/ML SUBCUTANEOUS SOLUTION
Gross
$48,976
551
$12,934
MEDICAL BACK PROBLEMS WITH MCC
Gross
$47,902
181
$12,766
RESPIRATORY NEOPLASMS WITH CC
Gross
$47,280
435
$12,737
MALIGNANCY OF HEPATOBILIARY SYSTEM OR PANCREAS WITH MCC
Gross
$47,172
J9334
$12,684
EFGARTIGIMOD ALFA 1008 MG-HYALURON-QVFC 11,200 UNIT/5.6 ML SUBCUT SOLN
Gross
$46,979
HC Ethicon- Human 2
$12,283
HC Ethicon- Human 2
Gross
$45,494
470
$12,168
MAJOR HIP AND KNEE JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MCC
Gross
$45,066
C9168
$12,148
MIRIKIZUMAB-MRKZ 300 MG/15 ML (20 MG/ML) INTRAVENOUS SOLUTION|DISCARDED DRUG NOT ADMINISTE
Gross
$44,994
J9217
$11,988
LEUPROLIDE ACETATE (6 MONTH) 45 MG INTRAMUSCULAR SYRINGE KIT
Gross
$44,399
J3380
$11,838
VEDOLIZUMAB 300 MG INTRAVENOUS SOLUTION
Gross
$43,843
J9316
$11,733
PERTUZUMAB 600 MG-TRASTUZUMAB 600 MG-HYALURONID-ZZXF/10 ML SUBCUT SOLN
Gross
$43,456
371
$11,726
MAJOR GASTROINTESTINAL DISORDERS AND PERITONEAL INFECTIONS WITH MCC
Gross
$43,430
J9301
$11,398
OBINUTUZUMAB 1,000 MG/40 ML INTRAVENOUS SOLUTION
Gross
$42,213
J2323
$11,268
NATALIZUMAB 300 MG/15 ML INTRAVENOUS SOLUTION
Gross
$41,733
331
$11,143
MAJOR SMALL AND LARGE BOWEL PROCEDURES WITHOUT CC/MCC
Gross
$41,269
417
$11,053
LAPAROSCOPIC CHOLECYSTECTOMY WITHOUT C.D.E. WITH MCC
Gross
$40,937
854
$10,821
INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURES WITH CC
Gross
$40,077
963
$10,666
OTHER MULTIPLE SIGNIFICANT TRAUMA WITH MCC
Gross
$39,504
982
$10,639
EXTENSIVE O.R. PROCEDURES UNRELATED TO PRINCIPAL DIAGNOSIS WITH CC
Gross
$39,404
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| A9513 | LUTETIUM LU 177 DOTATATE 10 MCI/ML (370 MBQ/ML) INTRAVENOUS SOLUTION | $286,723 | $77,415 | — | — | 24 |
| A9607 | LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN 27 MCI/ML (1,000 MBQ/ML) IV SOLN | $233,486 | $63,041 | — | — | 24 |
| J9043 | CABAZITAXEL 10 MG/ML (FIRST DILUTION) INTRAVENOUS SOLUTION | $215,244 | $58,116 | — | — | 24 |
| J9347 | TREMELIMUMAB-ACTL 20 MG/ML INTRAVENOUS SOLUTION | $194,111 | $52,410 | — | — | 19 |
| J9226 | HISTRELIN 50 MG (65 MCG/DAY) IMPLANT KIT | $185,672 | $50,131 | — | — | 24 |
| J3357 | USTEKINUMAB 90 MG/ML SUBCUTANEOUS SYRINGE | $133,587 | $36,068 | — | — | 12 |
| J9359 | LONCASTUXIMAB TESIRINE-LPYL 10 MG INTRAVENOUS SOLUTION | $133,113 | $35,941 | — | — | 24 |
| J9229 | INOTUZUMAB OZOGAMICIN 0.9 MG(0.25 MG/ML INITIAL CONCENTRATION) IV SOLN | $112,169 | $30,286 | — | — | 24 |
| 149 | DYSEQUILIBRIUM | $101,751 | $27,473 | — | — | 14 |
| 563 | FRACTURE, SPRAIN, STRAIN AND DISLOCATION EXCEPT FEMUR, HIP, PELVIS AND THIGH WITHOUT MCC | $101,518 | $27,410 | — | — | 14 |
| J2350 | OCRELIZUMAB 30 MG/ML INTRAVENOUS SOLUTION | $96,683 | $26,104 | — | — | 24 |
| J2507 | PEGLOTICASE 8 MG/ML INTRAVENOUS SOLUTION | $89,582 | $24,187 | — | — | 24 |
| A9606 | RA-223 XOFIGO | $88,837 | $23,986 | — | — | 19 |
| 548 | SEPTIC ARTHRITIS WITH MCC | $88,284 | $23,837 | — | — | 14 |
| J9309 | POLATUZUMAB VEDOTIN-PIIQ 140 MG INTRAVENOUS SOLUTION | $87,177 | $23,538 | — | — | 24 |
| J9298 | NIVOLUMAB 240 MG-RELATLIMAB-RMBW 80 MG/20 ML INTRAVENOUS SOLUTION | $72,332 | $19,530 | — | — | 24 |
| 974 | HIV WITH MAJOR RELATED CONDITION WITH MCC | $71,608 | $19,334 | — | — | 14 |
| 386 | INFLAMMATORY BOWEL DISEASE WITH CC | $71,560 | $19,321 | — | — | 14 |
| J9345 | RETIFANLIMAB-DLWR 500 MG/20 ML INTRAVENOUS SOLUTION | $69,057 | $18,645 | — | — | 19 |
| 662 | MINOR BLADDER PROCEDURES WITH MCC | $68,502 | $18,496 | — | — | 14 |
| J1628 | GUSELKUMAB 200 MG/20 ML (10 MG/ML) INTRAVENOUS SOLUTION | $68,196 | $18,413 | — | — | 19 |
| 813 | COAGULATION DISORDERS | $60,306 | $16,283 | — | — | 14 |
| 152 | OTITIS MEDIA AND URI WITH MCC | $60,060 | $16,216 | — | — | 14 |
| J9042 | BRENTUXIMAB VEDOTIN 50 MG INTRAVENOUS SOLUTION | $59,452 | $16,052 | — | — | 24 |
| 542 | PATHOLOGICAL FRACTURES AND MUSCULOSKELETAL AND CONNECTIVE TISSUE MALIGNANCY WITH MCC | $55,616 | $15,016 | — | — | 14 |
| J9022 | ATEZOLIZUMAB 1,200 MG/20 ML (60 MG/ML) INTRAVENOUS SOLUTION | $54,356 | $14,676 | — | — | 24 |
| 382 | COMPLICATED PEPTIC ULCER WITHOUT CC/MCC | $53,055 | $14,325 | — | — | 14 |
| 064 | INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH MCC | $52,982 | $14,305 | — | — | 14 |
| J9119 | CEMIPLIMAB-RWLC 50 MG/ML INTRAVENOUS SOLUTION | $51,173 | $13,817 | — | — | 24 |
| 497 | LOCAL EXCISION AND REMOVAL OF INTERNAL FIXATION DEVICES EXCEPT HIP AND FEMUR WITHOUT CC/MCC | $49,690 | $13,416 | — | — | 14 |
| J9144 | DARATUMUMAB 1,800 MG-HYALURONIDASE-FIHJ 30,000 UNIT/15 ML SUBCUT SOLN | $49,272 | $13,303 | — | — | 19 |
| J9380 | TECLISTAMAB-CQYV 90 MG/ML SUBCUTANEOUS SOLUTION | $48,976 | $13,224 | — | — | 19 |
| 551 | MEDICAL BACK PROBLEMS WITH MCC | $47,902 | $12,934 | — | — | 14 |
| 181 | RESPIRATORY NEOPLASMS WITH CC | $47,280 | $12,766 | — | — | 14 |
| 435 | MALIGNANCY OF HEPATOBILIARY SYSTEM OR PANCREAS WITH MCC | $47,172 | $12,737 | — | — | 14 |
| J9334 | EFGARTIGIMOD ALFA 1008 MG-HYALURON-QVFC 11,200 UNIT/5.6 ML SUBCUT SOLN | $46,979 | $12,684 | — | — | 19 |
| HC Ethicon- Human 2 | HC Ethicon- Human 2 | $45,494 | $12,283 | — | — | 5 |
| 470 | MAJOR HIP AND KNEE JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MCC | $45,066 | $12,168 | — | — | 14 |
| C9168 | MIRIKIZUMAB-MRKZ 300 MG/15 ML (20 MG/ML) INTRAVENOUS SOLUTION|DISCARDED DRUG NOT ADMINISTE | $44,994 | $12,148 | — | — | 8 |
| J9217 | LEUPROLIDE ACETATE (6 MONTH) 45 MG INTRAMUSCULAR SYRINGE KIT | $44,399 | $11,988 | — | — | 24 |
| J3380 | VEDOLIZUMAB 300 MG INTRAVENOUS SOLUTION | $43,843 | $11,838 | — | — | 24 |
| J9316 | PERTUZUMAB 600 MG-TRASTUZUMAB 600 MG-HYALURONID-ZZXF/10 ML SUBCUT SOLN | $43,456 | $11,733 | — | — | 24 |
| 371 | MAJOR GASTROINTESTINAL DISORDERS AND PERITONEAL INFECTIONS WITH MCC | $43,430 | $11,726 | — | — | 14 |
| J9301 | OBINUTUZUMAB 1,000 MG/40 ML INTRAVENOUS SOLUTION | $42,213 | $11,398 | — | — | 24 |
| J2323 | NATALIZUMAB 300 MG/15 ML INTRAVENOUS SOLUTION | $41,733 | $11,268 | — | — | 19 |
| 331 | MAJOR SMALL AND LARGE BOWEL PROCEDURES WITHOUT CC/MCC | $41,269 | $11,143 | — | — | 14 |
| 417 | LAPAROSCOPIC CHOLECYSTECTOMY WITHOUT C.D.E. WITH MCC | $40,937 | $11,053 | — | — | 14 |
| 854 | INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURES WITH CC | $40,077 | $10,821 | — | — | 14 |
| 963 | OTHER MULTIPLE SIGNIFICANT TRAUMA WITH MCC | $39,504 | $10,666 | — | — | 14 |
| 982 | EXTENSIVE O.R. PROCEDURES UNRELATED TO PRINCIPAL DIAGNOSIS WITH CC | $39,404 | $10,639 | — | — | 14 |
Showing top 50 of 5,066 priced procedures, sorted by gross charge.
Data straight from this hospital's own published price file (45 CFR § 180). The grade scores how completely the file contains the six required data elements. It is a check of the file — not a CMS compliance ruling, and not a measure of quality of care.